<ul>
<li>Sanofi reported 1,212,212,936 issued shares as of April 30, 2026.     *      Real voting rights totaled 1,329,027,146, excluding treasury shares.    *      Theoretical voting rights stood at 1,346,241,660, including treasury shares. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sanofi SA published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202605191237OMX_____CNEWS_EN_GNW1001182891_en) on May 19, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)</li>
</ul>

SBIO

<p>Sanofi reported 1.21 billion issued shares and 1.33 billion real voting rights as of April 30, 2026. Theoretical voting rights, including treasury shares, stood at 1.35 billion.</p>

PUBT

Sanofi

ALPS Medical Breakthrough

First Trust NYSE Arca Biotech Index Fd

VanEck Biotech ETF

VG Health

Ark Genomic Revolution ETF

Health Care Select Sector SPDR

Direxion S&P Biotech Bull 3X

Invesco Biotechnology & Genome ETF

iShares Global Healthcare

iShares US Pharma

SPDR S&P Biotech

iShares Biotechnology ETF

Invesco Nasdaq Biotechnology ETF

Proshares Ultra Nasdaq Biotech

Sanofi reports 1.21 billion issued shares, 1.33 billion real voting rights as of April 30